{"SPADE_N_04891": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2009/0105151 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2009_0105151_A1", "Patent Type": "Patent Application", "Publication Date": "2009-4-23", "Family Info": "WO2009014615A2,WO2009014615A3", "Patent Title": "Amphipathic alpha-helical peptide compositions as antiviral agents.", "Abstract": "The invention features methods and compositions that exploit the ability of amphipathic alpha-helical (AH) peptides to cause disruption of lipid-containing vesicles, such as enveloped viruses, in a size-dependent manner."}], "Sequence Information": {"SPADE ID": "SPADE_N_04891", "Sequence": "IEQGMMLAEQFKQKALGLLQTASRHAEV", "Sequence Length": 28, "Peptide Name": "Sequence 81 from Patent US 20090105151", "Source": "Hepatitis C virus", "Biological Activity": ["Antimicrobial", "Antiviral"], "Frequent Amino Acids": "ALQ", "Absent Amino Acids": "CDNOPUWY", "Basic Residues": 4, "Acidic Residues": 3, "Hydrophobic Residues": 13, "Polar Residues": 15, "Positive Residues": 4, "Negative Residues": 3, "Mass": 3128.62, "PI": 6.76, "Net Charge": 1, "Hydrophobicity": -0.16, "Similar Sequences": []}}}